Evidence map›Paper›PMID 29284593›Full record

ArticleMolecular & cellular proteomics : MCP2018

Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using

Te-Yao Hsu, Jyun-Mu Lin, Mai-Huong T Nguyen, Feng-Hsiang Chung, Ching-Chang Tsai, Hsin-Hsin Cheng, Yun-Ju Lai, Hsuan-Ning Hung, Chien-Sheng Chen

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Developments and Applications of Functional Protein Microarrays.Molecular & cellular proteomics : MCP · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Te-Yao HsuFrom the ‡Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan; cchen103@gmail.com tyhsu@cgmh.org.tw.
Jyun-Mu Lin§Graduate Institute of Systems Biology and Bioinformatics, National Central University, Jhongli 32001, Taiwan.
Mai-Huong T Nguyen§Graduate Institute of Systems Biology and Bioinformatics, National Central University, Jhongli 32001, Taiwan.
Feng-Hsiang Chung§Graduate Institute of Systems Biology and Bioinformatics, National Central University, Jhongli 32001, Taiwan.
Ching-Chang TsaiFrom the ‡Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Hsin-Hsin ChengFrom the ‡Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Yun-Ju LaiFrom the ‡Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Hsuan-Ning HungFrom the ‡Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Chien-Sheng Chen§Graduate Institute of Systems Biology and Bioinformatics, National Central University, Jhongli 32001, Taiwan; cchen103@gmail.com tyhsu@cgmh.org.tw.
Kaohsiung Chang Gung Memorial Hospital · TWNational Central University · TWChang Gung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pre-eclampsia is one of the main causes of perinatal mortality and morbidity. Many biomarkers for diagnosing pre-eclampsia have been found but most have low accuracy. Therefore, a potential marker that can detect pre-eclampsia with high accuracy is required. Infection has been reported as a cause of pre-eclampsia. In recent years, protein microarray chips have been recognized as a strong and robust tool for profiling antibodies for infection diagnoses. The purpose of the present study was to profile antibodies in the human plasma of healthy and pre-eclamptic pregnancies to identify suitable biomarkers. In this study, an

Indexed as

AdultAmino Acid MotifsAmino Acid SequenceAntibodiesAntigensEscherichia coliEscherichia coli ProteinsFemaleHumansPre-EclampsiaPregnancyProtein Array AnalysisProtein BindingProteomeProteomicsAntibodiesAntigensEscherichia coli ProteinsProteomeAntibodiesantigenBiomarker: DiagnosticPlasma or serum analysispre-eclampsiaProtein arraySystems biology

Identifiers

PMID29284593
PMCPMC6072543
OpenAlexW2781223194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.